An organ-on-chip model of pulmonary arterial hypertension identifies a BMPR2-SOX17-prostacyclin signalling axis
A biomimetic inducible model of pulmonary arterial hypertension (PAH) is presented, combining natural and induced BMPR2 dysfunction with hypoxia in lung endothelial cells and blood-derived PAH cells to induce smooth muscle activation & proliferation.
Main Authors: | Alexander J. Ainscough, Timothy J. Smith, Maike Haensel, Christopher J. Rhodes, Adam Fellows, Harry J. Whitwell, Eleni Vasilaki, Kelly Gray, Adrian Freeman, Luke S. Howard, John Wharton, Benjamin Dunmore, Paul D. Upton, Martin R. Wilkins, Joshua B. Edel, Beata Wojciak-Stothard |
---|---|
Format: | Article |
Language: | English |
Published: |
Nature Portfolio
2022-11-01
|
Series: | Communications Biology |
Online Access: | https://doi.org/10.1038/s42003-022-04169-z |
Similar Items
-
Sequential combination therapy with parenteral prostacyclin in BMPR2 mutations carriers
by: Athénaïs Boucly, et al.
Published: (2022-01-01) -
Deficiency of Axl aggravates pulmonary arterial hypertension via BMPR2
by: Tatyana Novoyatleva, et al.
Published: (2021-08-01) -
Prostacyclin Synthesis and Prostacyclin Receptor Expression in the Porcine Myometrium: Prostacyclin Potential to Regulate Fatty Acid Transporters, Cytokines and Contractility-Related Factors
by: Agnieszka Blitek, et al.
Published: (2022-08-01) -
PTPN1 Deficiency Modulates BMPR2 Signaling and Induces Endothelial Dysfunction in Pulmonary Arterial Hypertension
by: Md Khadem Ali, et al.
Published: (2023-01-01) -
Homozygous missense variant in BMPR1A resulting in BMPR signaling disruption and syndromic features
by: Bianca E. Russell, et al.
Published: (2019-11-01)